ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. Dokkyo Journal of Medical Sciences
  2. 40(2) 2013

Positive Therapeutic Response to Bevacizumab Plus Paclitaxel in a Patient with Advanced, Life-Threatening Breast Cancer and Carcinomatous Lymphangitis:a Subsequent Treatment Change to Hormone Therapy

https://dmu.repo.nii.ac.jp/records/1101
https://dmu.repo.nii.ac.jp/records/1101
f1e1a4e7-e981-4bb5-a2b3-d86ed8ae5579
名前 / ファイル ライセンス アクション
KJ00008659039.pdf KJ00008659039.pdf (301.7 kB)
Item type [ELS]学術雑誌論文 / Journal Article(1)
公開日 2017-05-24
タイトル
タイトル Positive Therapeutic Response to Bevacizumab Plus Paclitaxel in a Patient with Advanced, Life-Threatening Breast Cancer and Carcinomatous Lymphangitis:a Subsequent Treatment Change to Hormone Therapy
言語 en
言語
言語 eng
キーワード
言語 en
主題 breast cancer
キーワード
言語 en
主題 bavacizumab
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
雑誌書誌ID
収録物識別子 AA00629581
論文名よみ
タイトル Positive Therapeutic Response to Bevacizumab Plus Paclitaxel in a Patient with Advanced, Life-Threatening Breast Cancer and Carcinomatous Lymphangitis:a Subsequent Treatment Change to Hormone Therapy
著者 Ishizuna, Kazuo

× Ishizuna, Kazuo

en Ishizuna, Kazuo

Search repository
Ninomiya, Jun

× Ninomiya, Jun

en Ninomiya, Jun

Search repository
Kojima, Makoto

× Kojima, Makoto

en Kojima, Makoto

Search repository
Kawashima, Miho

× Kawashima, Miho

en Kawashima, Miho

Search repository
Nishibayashi, Fumiko

× Nishibayashi, Fumiko

en Nishibayashi, Fumiko

Search repository
Nozaki, Miwako

× Nozaki, Miwako

en Nozaki, Miwako

Search repository
Yamagishi, Hidetsugu

× Yamagishi, Hidetsugu

en Yamagishi, Hidetsugu

Search repository
Ueda, Yoshihiko

× Ueda, Yoshihiko

en Ueda, Yoshihiko

Search repository
Oya, Masatoshi

× Oya, Masatoshi

en Oya, Masatoshi

Search repository
著者所属(英)
en
Breast Center, Dokkyo Medical University Koshigaya Hospital
著者所属(英)
en
Ninomiya Hospital
著者所属(英)
en
Breast Center, Dokkyo Medical University Koshigaya Hospital
著者所属(英)
en
Department of Radiology, Dokkyo Medical University Kosigaya Hospital
著者所属(英)
en
Department of Radiology, Dokkyo Medical University Kosigaya Hospital
著者所属(英)
en
Department of Radiology, Dokkyo Medical University Kosigaya Hospital
著者所属(英)
en
Department of Pathology, Dokkyo Medical University Kosigaya Hospital
著者所属(英)
en
Department of Pathology, Dokkyo Medical University Kosigaya Hospital
著者所属(英)
en
Breast Center, Dokkyo Medical University Koshigaya Hospital
記事種別(英)
内容記述タイプ Other
内容記述 Case Report
抄録(英)
内容記述タイプ Other
内容記述 We present a case of advanced, life-threatening breast cancer with carcinomatous lymphangitis treatedwith bevacizumab plus paclitaxel. A positive therapeutic response was achieved and the treatment was subsequentlychanged to hormone therapy.The patient was a 53-year-old postmenopausal woman with a non-contributory medical history. She presentedto a nearby hospital with chief complaints of continued exertional dyspnea and coughing since March2012. Physical findings included a palpable mass in the left breast, and the patient was referred and presentedto our hospital in May. Examinations at our hospital revealed left-sided breast cancer (estrogen receptorpositive, progesterone receptor positive, and no amplification of the human epidermal growth factorreceptor 2 by FISH). The patient had bone metastasis and carcinomatous lymphangitis (cT2N3cM1-stageIV). The condition was life threatening, and administration of bevacizumab plus weekly paclitaxel was initiatedwith the expectation of a high response rate. Coughing and dyspnea resolved two weeks later. CTscans were taken in August after the completion of 3 cycles and showed improvement in carcinomatouslymphangitis. No major side effects were observed due to bevacizumab plus weekly paclitaxel. When theCT scans were taken in December after the completion of 6 cycles, the primary lesion and lymph node metastaseswere reduced in size. In the lung field, there was no thickening of the interlobular septa or subpleuralinterstitium, and the findings of carcinomatous lymphangitis were improved. Thus, bevacizumab plus paclitaxelwere discontinued and the treatment was changed to oral letrozole (2.5 mg/day). The patient hasbeen followed up with no recurrence as of March 2013.
書誌情報 Dokkyo journal of medical sciences

巻 40, 号 2, p. 113-117, 発行日 2013-07-25
ISSN
収録物識別子タイプ ISSN
収録物識別子 03855023
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-20 15:56:38.261258
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3